B |
2020-05-26 21:11:32.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
LYTTON LAURENCE W |
5.2% |
view |
S |
2020-02-27 16:07:46.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PRICE T ROWE ASSOCIATES INC |
2.4% |
view |
S |
2020-02-14 12:23:07.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Serrado Capital LLC |
1.3% |
view |
S |
2020-01-31 15:29:04.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
FMR LLC |
4.642% |
view |
B |
2019-09-27 18:19:22.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
LYTTON LAURENCE W |
5.2% |
view |
B |
2019-02-14 14:09:11.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PRICE T ROWE ASSOCIATES INC |
7.0% |
view |
S |
2019-02-13 16:16:49.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
3.0% |
view |
B |
2018-02-12 10:01:45.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PUTNAM INVESTMENTS LLC |
12.0% |
view |
B |
2018-01-22 16:38:19.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
QIAGEN NV |
13.1% |
view |
S |
2017-08-31 17:36:12.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Novo Holdings A |
0.43% |
view |
S |
2017-08-23 09:07:03.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
8.3% |
view |
S |
2017-07-19 18:30:32.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Novo Holdings A |
15.9% |
view |
S |
2017-03-29 16:05:37.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
9.8% |
view |
S |
2017-03-10 15:31:32.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PUTNAM INVESTMENTS LLC |
8.1% |
view |
S |
2016-11-22 16:44:55.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
BlackRock Inc |
0.0% |
view |
B |
2016-02-16 11:56:06.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
FMR LLC |
9.846% |
view |
B |
2016-01-08 17:08:48.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
BlackRock Inc |
10.4% |
view |
B |
2015-05-20 16:40:13.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
16.12% |
view |